Trexquant Investment LP Organogenesis Holdings Inc. Transaction History

Trexquant Investment LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$4.74 - $8.15 $47,428 - $81,548	-10,006 Reduced 6.15%	152,749 $745,000
Q1 2022 May 13, 2022	BUY	$6.47 - $9.57 $955,942 - $1.41 Million	147,750 Added 984.67%	162,755 $1.24 Million
Q4 2021 Feb 14, 2022	BUY	$9.02 - $13.5 $135,345 - $202,567	15,005 New	15,005 $139,000

117

63.2M

25K

23.2K

Ticker ORGO
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 130,888,000
Market Cap $406M
Description
Organogenesis Holdings Inc., a regenerative medicine company develops, manufactures, and commercializes solutions for the advanced wound care, and surgical and sports medicine markets in the United States. The company's advanced wound care products include Affinity, an amniotic membrane wound covering in which viable cells growth factors/cytokin...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.